Cargando…
SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage
Cells respond to DNA damage by activating a complex array of signaling networks, which include the AMPK and mTOR pathways. After DNA double-strand breakage, ATM, a core component of the DNA repair system, activates the AMPK-TSC2 pathway, leading to the inhibition of the mTOR cascade. Recently, we sh...
Autores principales: | Lepore Signorile, Martina, Sanese, Paola, Di Nicola, Elisabetta, Fasano, Candida, Forte, Giovanna, De Marco, Katia, Disciglio, Vittoria, Latrofa, Marialaura, Pantaleo, Antonino, Varchi, Greta, Del Rio, Alberto, Grossi, Valentina, Simone, Cristiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670288/ https://www.ncbi.nlm.nih.gov/pubmed/37998381 http://dx.doi.org/10.3390/cells12222644 |
Ejemplares similares
-
SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer
por: De Marco, Katia, et al.
Publicado: (2023) -
The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging ‘nonmutational epigenetic reprogramming’ cancer hallmark
por: Fasano, Candida, et al.
Publicado: (2023) -
Identifying novel SMYD3 interactors on the trail of cancer hallmarks
por: Fasano, Candida, et al.
Publicado: (2022) -
Uncoupling p38α nuclear and cytoplasmic functions and identification of two p38α phosphorylation sites on β-catenin: implications for the Wnt signaling pathway in CRC models
por: Lepore Signorile, Martina, et al.
Publicado: (2023) -
APC Splicing Mutations Leading to In-Frame Exon 12 or Exon 13 Skipping Are Rare Events in FAP Pathogenesis and Define the Clinical Outcome
por: Disciglio, Vittoria, et al.
Publicado: (2021)